Loading provider…
Loading provider…
Neurological Surgery Physician in Norfolk, VA
NPI: 1154354785Primary Practice Location
Sentara Neurology & Neurosurgery Specialists
301 Riverview Ave, Norfolk, VA
Primary Employer
Sentara Medical Group
sentara.com
HQ Phone
Get M.D. Dana's Phone Numberphone_androidMobile
Get M.D. Dana's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
DC State Medical License
HI State Medical License
VA State Medical License
2003 - 2026
NC State Medical License
2020 - 2022
NY State Medical License
2020 - 2022
WA State Medical License
2013 - 2016
DC State Medical License
2009 - 2014
MD State Medical License
2011 - 2012
HI State Medical License
2005 - 2008

American Board of Neurological Surgery
Neurological Surgery
University of Washington
Fellowship • Neurosurgical Spine Surgery
2013 - 2014
MedStar Health Georgetown University
Residency • Neurological Surgery
2008 - 2013
Naval Medical Center (Portsmouth)
Internship • Transitional Year
2003 - 2004
Vanderbilt University School Of Medicine
medschool.vanderbilt.edu
Medical School
Until 2003
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 84 | 105 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 80 | 89 |
| 3 | 99204New patient office or other outpatient visit, 45-59 minutes | 62 | 62 |
| 4 | 99203New patient outpatient visit, total time 30-44 minutes | 44 | 44 |
| 5 | 22853Insertion of device into intervertebral disc space of spine and fusion of vertebrae | 38 | 78 |
Minimally invasive lateral approach to the thoracolumbar junction for corpectomy
Lead Sponsor: AbbVie
Intervention / Treatment: DRUG: Placebo, DRUG: Elezanumab